MedCity News

OCTOBER 31, 2022

Thermo Fisher Scientific’s acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It’s Thermo Fisher’s biggest acquisition since its 2021 buyout of contract research organization PPD.

Specialization 263

Specialization Biopharma 263

Pharmaceutical Technology

FEBRUARY 28, 2023

Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. This can result in reductions in costs for our customers.” Download to learn more.

Biopharma 94

Biopharma Manufacturing Training Engineering 94

European Pharmaceutical Review

MARCH 20, 2024

Single-use filtration systems can help streamline processes and enhance efficiency of biopharma production. Sterile filtration: The crucial line of defence against life-threatening microorganisms, with insights into diverse membrane technologies and specialized viral clearance solutions. Interested to know more?

Biopharma 64

Biopharma Specialization Manufacturing Medical 64

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.

Specialization 45

Specialization Leads Pharma Side effects 45

Pharmaceutical Technology

MARCH 22, 2023

The appeal of process intensification continues to grow in the biopharma industry as a means of not only increasing the productivity, but also improving sustainability. Chromatography and clarification play vital parts in biopharma manufacturing, yet there is room for improvement in processes to eliminate inefficiencies and increase yield.

Biopharma 52

Biopharma Manufacturing Engineering Specialization 52

Pharmaceutical Technology

JANUARY 20, 2023

Nevertheless, the potential for mAb therapies in treating medical conditions that have limited options means that biopharma companies are investing considerable resources in development. The post Overcoming challenges with scalability in biopharma manufacturing appeared first on Pharmaceutical Technology. Download to learn more.

Biopharma 52

Biopharma Manufacturing Engineering Specialization 52

European Pharmaceutical Review

JANUARY 9, 2023

In the first 11 months of 2022, biopharma M&A value dropped by 42 percent compared to 2021, with Pfizer’s acquisition of Biohaven , the single largest deal up to December 2022. Alliances were a significant focus for biopharma and companies’ M&A strategies in 2022. Biopharma alone held over $1.4

Biopharma 98

Biopharma Specialization Leads Competition 98

Pharmaceutical Technology

MARCH 3, 2023

For more information about how Baxter BioPharma Solutions manufacturing expertise can support your project, download the content below.  The post How a specialized commercial program management team can improve your customer experience and accelerate commercialization appeared first on Pharmaceutical Technology.

Specialization 52

Specialization Management Manufacturing Biopharma 52

European Pharmaceutical Review

FEBRUARY 21, 2023

How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? In the short term, the unique advantage the cannabis-based medicines sector has – unlike many other biopharma businesses – is the ability to get to revenue through the ‘specials’ framework.

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

PM360

JUNE 30, 2022

The unit will specialize in medical communications, medical affairs, real-world evidence, and outcomes research. It includes agency groups ApotheCom, Ashfield MedComms, and Nucleus Group as well as specialized medical services companies MediStrava and MedEvoke.

Specialization 97

Specialization Medical Healthcare Healthcare 97

MedCity News

JUNE 16, 2023

Regardless of the reasons, investors, pharma, and research organizations are recognizing that advanced digital health tools will be a significant competitive advantage and generate meaningful return on investment (ROI) in an industry that is becoming more personalized and specialized.

Pharma 311

Pharma Food and Drug Administration Recruitment Patients 311

pharmaphorum

JANUARY 11, 2023

The public listing market slumped to nine initial public offerings (IPOs) and five special purpose acquisition company (SPAC) deals in 2022, but partnering remained buoyant, with more than 2,900 deals signed. Roche tops biopharma partnering podium.

Biopharma 75

Biopharma Specialization Physicians Healthcare 75

European Pharmaceutical Review

AUGUST 9, 2022

Big Pharma accounted for about 77 percent of M&A spending in the biopharma sector in the second quarter. The biopharma industry has well over a trillion dollars in Firepower (a metric that measures a company’s deal-making capacity based on the strength of its balance sheet).

Pharma 69

Pharma Biopharma Leads Specialization 69

Pharmaceutical Technology

JULY 21, 2022

ZyVersa Therapeutics has signed a definitive business combination agreement with blank-check special purpose acquisition company (SPAC) Larkspur Health Acquisition. The deal, which will make ZyVersa a publicly traded biopharma company, values the merged entity at an estimated pro forma enterprise value of nearly $108.92m.

Specialization 59

Specialization Biopharma Marketing Management 59

Pharmaceutical Technology

OCTOBER 3, 2022

Myovant Sciences has rejected an acquisition offer worth $2.5bn from Sumitovant Biopharma and its wholly-owned subsidiary Sumitomo Pharma, citing it 'significantly undervalues' the company. The board of directors of Myovant constituted a special committee of independent directors including its audit committee members to assess the proposal.

Food and Drug Administration 52

Food and Drug Administration Specialization Biopharma Food 52

PM360

OCTOBER 3, 2023

Men’s Health: Nuvan Augustin Dassanaike, Senior Vice President Digital and Marketing Strategy & Operations, Accord BioPharma Nephrology/Urology: W. Director, Obesity Market Access Strategy, Novo Nordisk Medical Device/Diagnostics: Brett Sarnoff, Vice President of Marketing Medical Device & Pharma Systems, North America, B.

Education 122

Education Marketing Media Pharmaceutical 122

Pharmaceutical Technology

MAY 24, 2023

Nearly every biopharma with a portfolio of drugs in development spanning traditional small molecules and biologics and the newer CGT operates with separate clinical supply organizations per these therapy areas. CGT have highly unique and specialized manufacturing processes.

Manufacturing 98

Manufacturing Transportation Specialization Patients 98

Medico Reach

AUGUST 1, 2022

Whether you are a start-up looking for investment or are interested in working in venture capital (VC), the worldwide biopharma and MedTech industries are growing. In 2022, over $14 billion was funded in biopharma setup globally, and 37 major IPOs of VC-backed biotech company businesses raised a combined $4.2 The Venture Capitals.

Biopharma 52

Biopharma Healthcare Healthcare Engineering 52

Pharma Marketing Network

MARCH 25, 2022

Sunny’s healthcare marketing agency, Xavier Creative House, specializes in pharmaceutical, biotech, and medical device. Extension of the patient: expanding the role of caregivers in biopharma development. Reach out at swhite@xaviercreative.com. Connect at linkedin.com/in/sunnywhite/ . REFERENCES: Gilda’s Club. Accessed March 12, 2022.

Pharma 98

Pharma Education Training Transportation 98

pharmaphorum

JANUARY 10, 2023

As two in five pharma leaders say that moving to a consumer-first mindset is a priority for the next two years, digital customer experience agency Graphite Digital is to publish a special edition of its Contradiction Conundrum whitepaper report, released in partnership with Reuters Events Pharma last year.

Pharma 52

Pharma Specialization Sales Biopharma 52

European Pharmaceutical Review

OCTOBER 2, 2023

Eligible companies classified as start-ups and active in the pharma, biopharma, digital, or medical device sectors can exhibit. This special edition will introduce three new categories, acknowledging the remarkable wave of innovation that has engulfed the industry.

Manufacturing 105

Manufacturing Pharma Engineering Networking 105

PM360

JUNE 16, 2023

Managing the complexity of commercializing rare and orphan therapies requires specialized Marketing, Medical Affairs, and Market Access teams that are up to the task. Acknowledgements: Special thanks to Sonalee Agarwal, VP, Alnylam Pharmaceuticals, and Crystal Watson, Head of HEOR, Atara Bio for their contributions to this article.

Marketing 98

Marketing Management Insurance Specialization 98

pharmaphorum

OCTOBER 18, 2022

Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye care with breakthrough innovations, is to combine with the European Biotech Acquisition Corp (EBAC), a special purpose acquisition company (SPAC) that has screened over 100 European biotechnology companies.

Biopharma 59

Biopharma Management Specialization Physicians 59

PM360

APRIL 7, 2023

The health-conscious among us pay special attention to actively managing our sleep, exercise, vitamins, etc. Biopharma should pay special attention to this. Biopharma companies that bring patients together in-person can create a sense of belonging and support that is often missing in the digital realm. The list goes on.

Biopharma 52

Biopharma Patients Specialization Networking 52

pharmaphorum

SEPTEMBER 30, 2022

Therapeutic inhibition of NLRP3 can prevent the formation of the NLRP3 inflammasome, which in turn inhibits the production of pro-inflammatory cytokines like interleukin-1 beta and interleukin-18, and has attracted a lot of attention among biopharma companies.

Biopharma 59

Biopharma Specialization Sales Leads 59

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. GSK has already made moves in this direction this year with deals to buy cancer specialist Sierra Oncology for $1.9 billion and vaccine firm Affinivax for up to $3.3

Sales 52

Sales Biopharma Medicine Prescription 52

MedCity News

APRIL 11, 2024

This is a test of an excerpt. Test test test. Test testtesttest. Test The post Testing post publishing appeared first on MedCity News.

Specialization 147

Specialization Retail Medical Biopharma 147

PM360

NOVEMBER 21, 2022

Those in the biopharma industry can play a pivotal role in shortening the journey to diagnosis if they learn from patients what critical pieces had to fall into place before they were diagnosed. It’s also in these communities where biopharma finds the best opportunities to connect with their stakeholders.

Patients 52

Patients Medicine Biopharma Media 52

MedTechVets

JANUARY 4, 2024

The MedTech/Biopharma industry is a unique place where individuals get to make meaningful contributions that (if safe and efficacious) has real world impacts on real people needing help. MedTechVets Academy is a specialized program that provides more than generic advice about transitioning into medical-related career fields.

Medical 59

Medical Biopharma Recruitment Specialization 59

PM360

JUNE 24, 2024

A form of artificial intelligence (AI) specialized in voice cloning used Travis’ voice, as recorded over a decades-long career, to fill in the vocals of the song. Yet from a risk-mitigation perspective, we anticipate a cautious, measured approach by most biopharma companies. In the patient engagement space, the potential is immense.

Healthcare 52

Healthcare Healthcare Patients Side effects 52

The Marketing Advantage

APRIL 6, 2021

April 6, 2021 The biopharma industry rightfully places a great deal of emphasis on the importance of having a sales compensation plan that pays for performance. In order to truly pay for performance, a biopharma sales compensation plan must be designed such that it meets the following two attributes: Pay-for-Performance Attributes.

Sales 52

Sales Biopharma Marketing Specialization 52

Clarivate

MAY 24, 2023

With gene therapies, like any specialized treatment, payers are going to be very stringent in making sure patients meet the criteria for treatment, given the cost they’re carrying,” said Kiernan. Payers are also eyeing a variety of stringent utilization management measures to prevent unnecessary care and rein in costs.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

PM360

SEPTEMBER 15, 2022

In order to improve patient inclusivity in clinical trials, the biopharma industry must incorporate DEI in all processes. Baseline lab tests are common, but diagnostic testing, such as ECG, echocardiogram, and Ocular Coherence Tomography requiring specialized devices, have found their way into product labels and REMS programs.

Patients 98

Patients Healthcare Healthcare Marketing 98

The Marketing Advantage

MAY 8, 2023

This, in turn, calls for a more expert and specialized sales force. This calls for a more specialized and expert sales force, requiring longer and more rigorous hiring and training processes. Thus, one role of a rare disease sales force is education on the rare disease and its diagnosis.

Sales 52

Sales Physicians Consulting Education 52

The Marketing Advantage

JULY 10, 2023

We at The Marketing Advantage have been designing call plans based on sales, opportunity, potential, maintenance and growth for the biopharma industry for over 30 years. Part of Dynamic Targeting™ is giving sales representatives the freedom to make or not make that special effort as they see fit.

Sales 40

Sales Consulting Specialization Prospecting 40

PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Weiss has also made substantial efforts to give back to the community at large. Braun Medical, Inc.

Marketing 52

Marketing Education Pharmaceutical Media 52

PM360

AUGUST 24, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Weiss has also made substantial efforts to give back to the community at large. Braun Medical, Inc.

Marketing 52

Marketing Pharmaceutical Healthcare Healthcare 52